Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BYFrontiers in medicine

Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system

  • Jianghai He1
  • Yuwen Hu1
  • Hesong Pan2
  • Ziyang Jin1
  • Zheng Tu1
  • Hongyu Ye1
  • Caixiang Zhuang1
  • Qingxiang Yu1
  • Xiangting Wang3
  • Yanyan Zheng2
  • Qiong Yao2
  1. 1Department of Neurology, Postgraduate Training base Alliance of Wenzhou Medical University (Wenzhou People’s Hospital) , , ,
  2. 2Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People’s Hospital , , ,
  3. 3The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University , , ,
Read full textPDFCite

Related

  1. Reporting signals of selected extrapyramidal adverse events with four newer second-generation antipsychotics: a disproportionality analysis of FAERS spontaneous reports
    Pan Ma, Qin Xiao, Yunpei Zhao +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMCCrossrefEurope PMC
  2. Adverse drug withdrawal event signals in FAERS and Eudravigilance databases: a stratified disproportionality analysis study
    Z. Khan, C. McCarthy, K. Dalton +4
    medRxivPreprintCC BYFull text1 citedPharmacology & toxicologymedRxiv
  3. Disproportionality analysis of adverse event reporting with aspirin, statins, and their co-exposure in FAERS, 2004–2025
    Zuofeng Cao, Baojun Xie, Ping Lai +7
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. A disproportionality analysis of adverse event reports for givinostat in the FDA adverse event reporting system (FAERS) database
    Lin Chen, Hanyu Zhang, Yunlong Wang +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  5. Infectious Complications and Toxicities of the Teclistamab Plus Daratumumab Combination in Relapsed or Refractory Multiple Myeloma: A Disproportionality and Drug–Interaction Analysis of the FDA Adverse Event Reporting System
    Carmel Awadallah, Sohaib Irfan, Al-Ola Abdallah +1
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{he2026agestratified,
  title = {{Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system}},
  author = {Jianghai He and Yuwen Hu and Hesong Pan and Ziyang Jin and Zheng Tu and Hongyu Ye and Caixiang Zhuang and Qingxiang Yu and Xiangting Wang and Yanyan Zheng and Qiong Yao},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13668812},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system
AU  - Jianghai He
AU  - Yuwen Hu
AU  - Hesong Pan
AU  - Ziyang Jin
AU  - Zheng Tu
AU  - Hongyu Ye
AU  - Caixiang Zhuang
AU  - Qingxiang Yu
AU  - Xiangting Wang
AU  - Yanyan Zheng
AU  - Qiong Yao
PY  - 2026
DA  - 2026/10/19
JO  - Frontiers in medicine
UR  - https://europepmc.org/article/PMC/PMC13668812
SN  - 2296-858X
ER  -